Aldactide(R)

SECTION 2: Hazards identification

Appearance: Tablets: buff , film-coated

Signal word

WARNING

Hazard statements

Antihypertensive drug: has blood pressure-lowering properties Suspected of damaging fertility. Suspected of causing cancer. May cause damage to: blood and blood forming organs through prolonged or repeated exposure.

Additional information

Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on blood, kidneys, reproductive system. Known Clinical Effects: Signs and symptoms might include nausea, vomiting, cramps, dizziness, headache, vertigo, low blood pressure on standing, rash, urticaria, photosensitivity, electrolyte imbalance, muscle spasm, weakness, and restlessness. Hypersensitivity reactions may also occur in susceptible individuals. Effects on blood and blood-forming organs have also occurred. EU Indication of danger: Harmful Toxic to Reproduction: Category 2 Carcinogenic: Category 3 EU Hazard Symbols: EU Risk Phrases: R40 - Limited evidence of a carcinogenic effect R48/22 - Harmful: danger of serious damage to health by prolonged exposure if swallowed. R60 - May impair fertility. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.